About MRA » Letter from the President
It’s been a busy and productive few weeks as we’ve welcomed exciting progress from MRA-funded investigators working to maximize success with the newly approved therapies for patients, celebrated final passage of the Sunscreen Innovation Act, and traveled to Switzerland to participate in the Society for Melanoma Research’s International Congress. Among the highlights from that meeting were presentations by two dozen MRA-supported researchers, including the first results from two different Phase 3 clinical trials involving anti-PD-1 antibodies, rational combinations, and other approaches to defeating melanoma. You can read a summary of the event here.
The deadlines for MRA’s annual Request for Proposals have just passed, once again yielding a robust collection of grant applications from institutions around the world. The MRA science team and Grant Review Committee have already begun the process of vetting these applications which hail from investigators and institutions around the world, a process that will continue into 2015. MRA plans to award at least $7 million in new research awards early next spring.
|Click to Read|
We are pleased to present MRA’s latest Progress report, which reviews highlights of our activities for 2013-2014. This report can be viewed and downloaded from our website by clicking here.
As Thanksgiving and the gift-giving season approach, MRA remains incredibly grateful for the ongoing generous support of our founders, Board, donors, allies and partners. As you plan your charitable giving during the holiday season, I hope you will consider supporting MRA for Giving Tuesday on December 2 and by designating MRA as your charity of choice through the AmazonSmile program. As always, one hundred percent of your donations will go directly to support our research program.
Thank you for all that you do in collaboration with MRA as we work to defeat deadly melanoma. Together we are catalyzing an incredible time of progress and innovation.
Wendy K.D. Selig
President and CEO
MELANOMA RESEARCH ALLIANCE FOUNDATION (Melanoma Research Alliance; MRA) is a GuideStar Exchange Gold Participant Want to learn more about the GuideStar Exchange?
Click here »